-
公开(公告)号：EP4245376A3
公开(公告)日：2023-12-13
申请号：EP23169814.3
申请日：2015-10-13
发明人： FREEMAN, Gordon, James , SHARPE, Arlene, Helen , FREY, Gerhard, Johann , CHANG, Hwai, Wen , MATARAZA, Jennifer, Marie , DRANOFF, Glenn
IPC分类号： A61K39/395 , C07K16/28 , C07K16/46 , A61P31/00 , A61P35/00 , A61P37/02 , A61P35/02 , C07K16/30
摘要： Antibody molecules that specifically bind to PD-L1 are disclosed. Combination therapies comprising the anti-PD-L1 antibody molecules are also disclosed. The anti-PD-L1 antibody molecules can be used to treat, prevent and/or diagnose cancerous or infectious conditions and disorders.
-
公开(公告)号：EP4378957A3
公开(公告)日：2024-08-07
申请号：EP24154217.4
申请日：2016-07-28
发明人： DRANOFF, Glenn , FREEMAN, Gordon, James , SHARPE, Arlene, Helen , BLATTLER, Walter, A. , MATARAZA, Jennifer, Marie , SABATOS-PEYTON, Catherine, Anne , CHANG, Hwai, Wen , FREY, Gerhard, Johann
CPC分类号： A61K39/00 , A61K2039/50520130101 , C07K2317/2420130101 , C07K2317/7620130101 , C07K2317/9220130101 , C07K16/2818 , A61P35/00
摘要： Combination therapies comprising antibody molecules that specifically bind to PD-1 are disclosed. The combination therapies can be used to treat or prevent cancerous or infectious conditions and disorders.
-
公开(公告)号：EP3206711A1
公开(公告)日：2017-08-23
申请号：EP15784907.6
申请日：2015-10-13
发明人： FREEMAN, Gordon, James , SHARPE, Arlene, Helen , FREY, Gerhard, Johann , CHANG, Hwai, Wen , MATARAZA, Jennifer, Marie , DRANOFF, Glenn
IPC分类号： A61K39/395 , C07K16/28 , C07K16/46
CPC分类号： C07K16/2827 , A61K39/3955 , A61K39/39558 , A61K45/06 , A61K2039/505 , A61N5/10 , C07K16/30 , C07K16/3023 , C07K16/3046 , C07K16/3053 , C07K16/3069 , C07K2317/14 , C07K2317/21 , C07K2317/24 , C07K2317/31 , C07K2317/33 , C07K2317/56 , C07K2317/565 , C07K2317/567 , C07K2317/76 , C07K2317/92 , G01N33/57492 , G01N2333/70532
摘要： Antibody molecules that specifically bind to PD-L1 are disclosed. Combination therapies comprising the anti-PD-L1 antibody molecules are also disclosed. The anti-PD-L1 antibody molecules can be used to treat, prevent and/or diagnose cancerous or infectious conditions and disorders.
摘要翻译： 公开了特异性结合PD-L1的抗体分子。 还公开了包含抗PD-L1抗体分子的组合疗法。 抗PD-L1抗体分子可用于治疗，预防和/或诊断癌症或感染性病症和障碍。
-
4.发明公开ANTIBODY MOLECULES TO PD-1 AND USES THEREOF 审中-公开ANTIKÖRPERMOLEKÜLEGEGEN PD-1 UND VERWENDUNGEN DAVON
公开(公告)号：EP3097121A1
公开(公告)日：2016-11-30
申请号：EP15703384.6
申请日：2015-01-23
发明人： FREEMAN, Gordon, James , SHARPE, Arlene, Helen , BLATTLER, Walter, A. , MATARAZA, Jennifer, Marie , SABATOS-PEYTON, Catherine, Anne , CHANG, Hwai, Wen , FREY, Gerhard, Johann
IPC分类号： C07K16/28
CPC分类号： C07K16/2818 , A61K39/3955 , A61K45/06 , C07K16/2896 , C07K2317/24 , C07K2317/31 , C07K2317/565 , C07K2317/569 , C07K2317/74 , C07K2317/76 , C07K2317/92 , G01N33/566 , G01N33/57484 , G01N33/6854 , G01N2333/70596 , Y02A50/58
摘要： Antibody molecules that specifically bind to PD-1 are disclosed. The anti-PD-1 antibody molecules can be used to treat, prevent and/or diagnose cancerous or infectious conditions and disorders.
摘要翻译： 公开了特异性结合PD-1的抗体分子。 抗PD-1抗体分子可用于治疗，预防和/或诊断癌性或感染性疾病和病症。
-
公开(公告)号：EP4378957A2
公开(公告)日：2024-06-05
申请号：EP24154217.4
申请日：2016-07-28
发明人： DRANOFF, Glenn , FREEMAN, Gordon, James , SHARPE, Arlene, Helen , BLATTLER, Walter, A. , MATARAZA, Jennifer, Marie , SABATOS-PEYTON, Catherine, Anne , CHANG, Hwai, Wen , FREY, Gerhard, Johann
IPC分类号： C07K16/28
CPC分类号： A61K39/00 , A61K2039/50520130101 , C07K2317/2420130101 , C07K2317/7620130101 , C07K2317/9220130101 , C07K16/2818 , A61P35/00
摘要： Combination therapies comprising antibody molecules that specifically bind to PD-1 are disclosed. The combination therapies can be used to treat or prevent cancerous or infectious conditions and disorders.
-
公开(公告)号：EP4245376A2
公开(公告)日：2023-09-20
申请号：EP23169814.3
申请日：2015-10-13
发明人： FREEMAN, Gordon, James , SHARPE, Arlene, Helen , FREY, Gerhard, Johann , CHANG, Hwai, Wen , MATARAZA, Jennifer, Marie , DRANOFF, Glenn
IPC分类号： A61P37/02
摘要： Antibody molecules that specifically bind to PD-L1 are disclosed. Combination therapies comprising the anti-PD-L1 antibody molecules are also disclosed. The anti-PD-L1 antibody molecules can be used to treat, prevent and/or diagnose cancerous or infectious conditions and disorders.
-
7.发明公开
公开(公告)号：EP3393504A1
公开(公告)日：2018-10-31
申请号：EP16825970.3
申请日：2016-12-21
申请人： Novartis AG , The Trustees of The University of Pennsylvania , Dana-Farber Cancer Institute, Inc. , President and Fellows of Harvard College
发明人： BROGDON, Jennifer , CHANG, Hwai, Wen , ENGELS, Boris , FREEMAN, Gordon, James , FREY, Gerhard, Johann , MATARAZA, Jennifer, Marie , SINGH, Reshma , SHARPE, Arlene, Helen
IPC分类号： A61K39/00
CPC分类号： A61K39/0011 , A61K2039/505 , A61K2039/5158 , A61K2039/545
摘要： Provided are compositions for use in methods for treating diseases associated with expression of mesothelin comprising administering a cell that expresses a chimeric antigen receptor (CAR) specific to mesothelin in combination with a PD-L1 inhibitor.
-
公开(公告)号：EP3328418A1
公开(公告)日：2018-06-06
申请号：EP16750330.9
申请日：2016-07-28
发明人： DRANOFF, Glenn , FREEMAN, Gordon, James , SHARPE, Arlene, Helen , BLATTLER, Walter, A. , MATARAZA, Jennifer, Marie , SABATOS-PEYTON, Catherine, Anne , CHANG, Hwai, Wen , FREY, Gerhard, Johann
CPC分类号： C07K16/2818 , A61K39/00 , A61K39/39541 , A61K2039/505 , A61P35/00 , C07K2317/24 , C07K2317/56 , C07K2317/76 , C07K2317/92
摘要： Combination therapies comprising antibody molecules that specifically bind to PD-1 disclosed. The combination therapies can be used to treat or prevent cancerous or infectious conditions and disorders.
-
公开(公告)号：EP3514179A1
公开(公告)日：2019-07-24
申请号：EP18211373.8
申请日：2015-01-23
发明人： FREEMAN, Gordon, James , SHARPE, Arlene, Helen , BLATTLER, Walter, A. , MATARAZA, Jennifer, Marie , SABATOS-PEYTON, Catherine, Anne , CHANG, Hwai, Wen , FREY, Gerhard, Johann
IPC分类号： C07K16/28 , C07K16/30 , A61K39/395
摘要： Antibody molecules that specifically bind to PD-1 are disclosed. The anti-PD-1 antibody molecules can be used to treat, prevent and/or diagnose cancerous or infectious conditions and disorders.
-
-
-
-
-
-
-
-
搜索结果
9 条记录 (耗时 0.037 秒)
